Abstract

Psychotropic Medications in the Treatment of Feline Urine Spraying

Author(s): Simpson Barbara Sherman, Vail Jane

Issue: Jan/Feb 2007 - Pediatric Patients

Page(s): 44-48

Download in electronic PDF format for $75
  • Psychotropic Medications in the Treatment of Feline Urine Spraying Page 1
  • Psychotropic Medications in the Treatment of Feline Urine Spraying Page 2
  • Psychotropic Medications in the Treatment of Feline Urine Spraying Page 3
  • Psychotropic Medications in the Treatment of Feline Urine Spraying Page 4
  • Psychotropic Medications in the Treatment of Feline Urine Spraying Page 5

Abstract

Urine spraying (urine marking) is one of the most prevalent feline behavior disorders and a common reason for veterinarian consultation. Although urine spraying is a normal feline communication signal, it is unacceptable behavior for house cats, and, if untreated, can lead to relinquishment, relegation outside, or even euthanasia. Urine spraying is associated with a medical disorder in up to 25% of cats that present for treatment; hence all cats that spray should undergo clinical examination by a veterinarian to rule out physical causes before a psychogenic cause can be presumed. Behavioral treatment involves litter box management and medication. A variety of psychotropic medications have proven safe and effective for the long-term treatment of psychogenic feline urine spraying, but only if they are prescribed appropriately, monitored judiciously, and coupled therapeutically with environmental management. The goal of such therapy is to reduce the incidence of urine marking to a level acceptable to the owner. Compounding pharmacists perform an essential function in modifying doses of manufactured anxiolytic and antidepressant medications for use in cats whose spraying is psychogenic in origin. In this article, the case is reported of a cat successfully treated with psychotropic medication to reduce the incidence of urine marking, and medications compounded for that purpose are briefly reviewed. The role of the compounding pharmacist in ensuring the success of treatment is also discussed.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2007
Pg. 44-48
Mar/Apr 2003
Pg. 106-113
Author(s): Davidson Gigi S
Nov/Dec 2006
Pg. 418
Author(s): Fields Shannon W
May/Jun 2014
Pg. 253-255
Nov/Dec 2022
Pg. 468-472
Jul/Aug 2003
Pg. 266-270
Author(s): Kuntz Rachael
Mar/Apr 2001
Pg. 92-94
Author(s): Davidson Michael G
Sep/Oct 2008
Pg. 392-397
Jul/Aug 2016
Pg. 271-274
Author(s): Eichstadt Lauren R
May/Jun 2017
Pg. 242-246
Jan/Feb 2018
Pg. 57
Author(s): Allen Loyd V Jr
Nov/Dec 2006
Pg. 411-414
Author(s): Davidson Gigi S
Jul/Aug 2003
Pg. 288-291
Author(s): Glasnapp Andrew
Nov/Dec 2010
Pg. 488-491
Sep/Oct 2003
Pg. 345-347
Author(s): Davidson Gigi S
May/Jun 2020
Pg. 194-197
Jul/Aug 2020
Pg. 327-336
Nov/Dec 2017
Pg. 446-452
May/Jun 2010
Pg. 182-192
May/Jun 2003
Pg. 170-174
Author(s): Meece Jerry